Up-and-coming and established technology leaders

Resident Companies

Already at PARK INNOVAARE

At PARK INNOVAARE, we offer high-tech companies of all sizes the best possible conditions for cross-industry collaboration and the realization of their R&D projects. With our modern infrastructure, close interaction with the Paul Scherrer Institute (PSI), and our network of research and industrial partners, we support our resident companies in achieving their next breakthrough.

Advanced Accelerator Technologies AG

×

Advanced Accelerator Technologies AG (AAT) was founded in 2015 as a joint initiative between the Paul Scherrer Institute (PSI) and a range of industry partners. AAT's main aim is to commercialize the PSI’s leading know-how concerning accelerators, experimentation, and large facilities, as well as the Institute’s outstanding application expertise regarding particle beams and photons in the areas of science, research, and industrial processes.

Advanced Accelerator Technologies AG (AAT) was founded in 2015 as a joint initiative between the Paul Scherrer Institute (PSI) and a range of industry partners. AAT's main aim is to commercialize the PSI’s leading know-how concerning accelerators, experimentation, and large facilities, as well as the Institute’s outstanding application expertise regarding particle beams and photons in the areas of science, research, and industrial processes.

Crystallise! AG

×

Crystallise! AG is a young company that provides crystallographic services for identifying small molecule compounds and targets the chemical, pharmaceutical, and agro-industries.

Crystallise! AG is a young company that provides crystallographic services for identifying small molecule compounds and targets the chemical, pharmaceutical, and agro-industries.

Excelsus Structural Solutions (Swiss) AG

×

Excelsus is a spin-off company of the Paul Scherrer Institute (PSI). It offers fast, easy, and affordable access to state-of-the-art characterization tools for the structural and microstructural analysis of materials (pharmaceuticals, food and aroma compounds, pigments, polymers, and various other chemicals) for selecting, developing and manufacturing high-quality products.

Excelsus is a spin-off company of the Paul Scherrer Institute (PSI). It offers fast, easy, and affordable access to state-of-the-art characterization tools for the structural and microstructural analysis of materials (pharmaceuticals, food and aroma compounds, pigments, polymers, and various other chemicals) for selecting, developing and manufacturing high-quality products.

Cosylab Switzerland GmbH

×

Cosylab Switzerland GmbH provides systems integration and customized products and solutions, covering the full range of control systems and instrumentation. Cosylab Switzerland was involved in the development of large-scale distributed control systems for PSI’s SwissFEL and SLS facilities.

Cosylab Switzerland GmbH provides systems integration and customized products and solutions, covering the full range of control systems and instrumentation. Cosylab Switzerland was involved in the development of large-scale distributed control systems for PSI’s SwissFEL and SLS facilities.

GratXray AG

×

GratXray, a high-tech spin-off of the PSI and ETH Zurich, is developing, producing, and commercializing a grating interferometry-based breast computed tomography (GIBCT) system. Their technology allows for more precise breast cancer imaging. It will significantly reduce the number of false positives and improve patients’ comfort during the procedure.

GratXray, a high-tech spin-off of the PSI and ETH Zurich, is developing, producing, and commercializing a grating interferometry-based breast computed tomography (GIBCT) system. Their technology allows for more precise breast cancer imaging. It will significantly reduce the number of false positives and improve patients’ comfort during the procedure.

InterAx Biotech AG

×

InterAx is uniquely positioned to assist GPCR drug candidate design and selection by integrating bioanalytical and computational pharmacology on collaborative projects with biotech and pharma companies. InterAx applies mathematical models and simulations to in-house-derived bioanalytical data to address the complexity of drug-induced cellular signaling mechanisms. The company's goal is to close the gap between laboratory experiments and in vivo studies by streamlining the critical processes of drug candidate design and selection, thereby significantly reducing the risks, costs and duration of drug discovery and the development of new drugs.

InterAx is uniquely positioned to assist GPCR drug candidate design and selection by integrating bioanalytical and computational pharmacology on collaborative projects with biotech and pharma companies. InterAx applies mathematical models and simulations to in-house-derived bioanalytical data to address the complexity of drug-induced cellular signaling mechanisms. The company's goal is to close the gap between laboratory experiments and in vivo studies by streamlining the critical processes of drug candidate design and selection, thereby significantly reducing the risks, costs and duration of drug discovery and the development of new drugs.

leadXpro AG

×

Specializing in the development and optimization of pharmaceutical active substances, leadXpro AG applies research from the Paul Scherrer Institute (PSI) in the field of membrane proteins, as well as world-leading technologies to investigate protein structures. The new large research facility at the PSI, the SwissFEL (launched in 2016), also offers excellent potential for this close collaboration.

Specializing in the development and optimization of pharmaceutical active substances, leadXpro AG applies research from the Paul Scherrer Institute (PSI) in the field of membrane proteins, as well as world-leading technologies to investigate protein structures. The new large research facility at the PSI, the SwissFEL (launched in 2016), also offers excellent potential for this close collaboration.

Molecular Modeling Laboratory (MML)

×

Molecular Modeling Laboratory (MML) applies high-throughput quantum chemical modeling, Artificial Intelligence (AI) heuristics, and state-of-the-art electron microscopy to the study and development of life science immunointerventions and drug design. Quantum Immunology, MML’s flagship initiative, addresses how quantum mechanics translate into receptor-antigen triggering and how this knowledge may be applied to the therapy of infectious diseases, immune disorders, neurological conditions and aging. MML also combines theoretical modeling and Electron Energy Loss Spectroscopy (EELS) to optimize drug design by detecting new polymorphic crystal structures and analyzing pharmaceutical Amorphous Solid Dispersion (ASD) dynamics.

Molecular Modeling Laboratory (MML) applies high-throughput quantum chemical modeling, Artificial Intelligence (AI) heuristics, and state-of-the-art electron microscopy to the study and development of life science immunointerventions and drug design. Quantum Immunology, MML’s flagship initiative, addresses how quantum mechanics translate into receptor-antigen triggering and how this knowledge may be applied to the therapy of infectious diseases, immune disorders, neurological conditions and aging. MML also combines theoretical modeling and Electron Energy Loss Spectroscopy (EELS) to optimize drug design by detecting new polymorphic crystal structures and analyzing pharmaceutical Amorphous Solid Dispersion (ASD) dynamics.

Nomoko AG

×

Nomoko AG has developed a new technology to produce cost-effective and compact, extremely high-resolution cameras. It is aiming to develop a 1-gigapixel camera that is smaller than a conventional digital single-lens reflex camera. Thanks to their superlative resolution, the resulting images have an extremely high level of detail and information density, rendering them ideal for use in 3D modelling. The company has also developed a software to process those imaged into 3D models forming the digital twin of the world. 

Nomoko AG has developed a new technology to produce cost-effective and compact, extremely high-resolution cameras. It is aiming to develop a 1-gigapixel camera that is smaller than a conventional digital single-lens reflex camera. Thanks to their superlative resolution, the resulting images have an extremely high level of detail and information density, rendering them ideal for use in 3D modelling. The company has also developed a software to process those imaged into 3D models forming the digital twin of the world. 

novoMOF AG

×

A technology company in the field of advanced materials, novoMOF AG focuses on the synthesis and production of metal-organic frameworks (MOF). MOFs are novel materials that offer competitive applications in various industrial sectors. For instance, battery charging times can be reduced to minutes, the shelf life of packaged food can be prolonged, or gases such as carbon dioxide can be separated, purified, or stored. The company partners with leaders from different industries who want to exploit MOFs as an innovation opportunity at an early stage.

A technology company in the field of advanced materials, novoMOF AG focuses on the synthesis and production of metal-organic frameworks (MOF). MOFs are novel materials that offer competitive applications in various industrial sectors. For instance, battery charging times can be reduced to minutes, the shelf life of packaged food can be prolonged, or gases such as carbon dioxide can be separated, purified, or stored. The company partners with leaders from different industries who want to exploit MOFs as an innovation opportunity at an early stage.

Securaxis AG

×

Using AI, sound localization, and Internet of Things (IoT) technology, Securaxis has developed a real-time high-energy event detection sensor to identify and characterize sounds. It is designed to be integrated into the environment where video camera installations are not suitable for technical or privacy reasons. Their device will help authorities (police, traffic authorities, fire departments) overcome daily challenges by providing early awareness signals when there are explosions or extreme energy events, such as fires or collisions, thus keeping them informed of ongoing situations in real time and reducing the number of false alarms.

Using AI, sound localization, and Internet of Things (IoT) technology, Securaxis has developed a real-time high-energy event detection sensor to identify and characterize sounds. It is designed to be integrated into the environment where video camera installations are not suitable for technical or privacy reasons. Their device will help authorities (police, traffic authorities, fire departments) overcome daily challenges by providing early awareness signals when there are explosions or extreme energy events, such as fires or collisions, thus keeping them informed of ongoing situations in real time and reducing the number of false alarms.

Swiss Hydrogen SA

×

Swiss Hydrogen SA was founded in 2008 as a subsidiary of Belenos Clean Power Holding to develop and market electrolysis products and services. The company works on clean energy solutions based on hydrogen for a variety of applications, enabling zero-emission electricity production. In 2018, French automotive supplier Plastic Omnium acquired Swiss Hydrogen.

Swiss Hydrogen SA was founded in 2008 as a subsidiary of Belenos Clean Power Holding to develop and market electrolysis products and services. The company works on clean energy solutions based on hydrogen for a variety of applications, enabling zero-emission electricity production. In 2018, French automotive supplier Plastic Omnium acquired Swiss Hydrogen.

Swiss Terahertz GmbH

×

Swiss Terahertz is a start-up based on some of the world's most unique terahertz technologies developed at the SwissFEL. It specializes in the fabrication and R&D of terahertz systems, including highly-efficient nonlinear organic crystals. Swiss Terahertz products can be integrated both in specialized research infrastructures and in commercial spectrometers for security inspection, pharma, and non-destructive testing.

Swiss Terahertz is a start-up based on some of the world's most unique terahertz technologies developed at the SwissFEL. It specializes in the fabrication and R&D of terahertz systems, including highly-efficient nonlinear organic crystals. Swiss Terahertz products can be integrated both in specialized research infrastructures and in commercial spectrometers for security inspection, pharma, and non-destructive testing.

V Carbon GmbH

×

V Carbon is the developer and owner of a proprietary and commercially viable recycling solution for carbon fiber, along with a complete materials and engineering ecosystem for sustainable and engineered composites. The company's environmentally sustainable recycling platform delivers a genuine solution for the significant, ever-increasing amounts of production scrap and end-of-life waste from the aerospace, industrial, and automotive sectors.

V Carbon is the developer and owner of a proprietary and commercially viable recycling solution for carbon fiber, along with a complete materials and engineering ecosystem for sustainable and engineered composites. The company's environmentally sustainable recycling platform delivers a genuine solution for the significant, ever-increasing amounts of production scrap and end-of-life waste from the aerospace, industrial, and automotive sectors.